Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) | OX Receptor antibody

Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.

Purity & Quality Control

Batch: A281401 Purity: 99% Protein concentration: 10.36mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective OX Receptor Inhibitors

Biological Activity

Description	Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.

References
[1] Kuang Z, et al. Cancer Immunol Immunother. 2020;69(6):939-950.

References

[1] Kuang Z, et al. Cancer Immunol Immunother. 2020;69(6):939-950.

Product Details

CAS No.	2244739-29-3
Molecular Weight	145.94
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field